Thermo Fisher Scientific recently received U.S. 510(k) clearance for its EXENT System, an automated analyser aimed at ...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced 510(k) clearance of the EXENT® Analyser and Immunoglobulin Isotypes (GAM) Assay**, a first-of-its-kind ...
Thermo Fisher Scientific has cleared a major regulatory hurdle in getting a new diagnostic tool for a type of blood cancer in ...
Designed for routine clinical use, the system can identify M-proteins based on their molecular weight to help diagnose multiple myeloma and related disorders.
Thermo Fisher Scientific received 510 (k) clearance from the Food and Drug Administration to market its EXENT system to aid in the diagnosis of multiple myeloma. The company's EXENT system detects and ...
Article ‘Count’ and ‘Share’ for Thermo Fisher Scientific K.K. based on listed parameters only. The articles listed below published by authors from Thermo Fisher Scientific K.K., organized by journal ...
No articles found. Thermo Fisher Scientific K.K. did not contribute to any primary research papers from Nature Index journals in the current 12 month window. The following affiliated institutions are ...